Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Clin Immunol. 2009 May 26;132(3):401–411. doi: 10.1016/j.clim.2009.05.002

Figure 3. Differential expression of gC1qR on CD4+ T cells of individuals that resolve HCV infection and those that become chronically infected.

Figure 3

A) Representative gC1qR staining of PBMC from a healthy donor, an acute-to-resolved patient (Month 0) and an acute-to-chronic patient (Month 0) after gating down to the CD4+CD3+ lymphocytes. B) Compiled relative gC1qR expression (%gC1qR+ -%FMO) on CD4+ T cells from healthy controls, acutely infected individuals (Month 0) and those same individuals roughly six months later (Month 6), at which time chronicity or resolution were determined. Horizontal bar indicates median. Mann-Whitney analysis. P-value significance is p<0.05.